239 related articles for article (PubMed ID: 33634860)
21. Performance of lung cancer screening with low-dose CT in Gejiu, Yunnan: A population-based, screening cohort study.
Wei MN; Su Z; Wang JN; Gonzalez Mendez MJ; Yu XY; Liang H; Zhou QH; Fan YG; Qiao YL
Thorac Cancer; 2020 May; 11(5):1224-1232. PubMed ID: 32196998
[TBL] [Abstract][Full Text] [Related]
22. Examination of Chronic Smoking Behavior and Eligibility for Low-Dose Computed Tomography for Lung Cancer Screening Among Older Chinese Male Smokers.
Li CC; Matthews AK; Dong X
J Gerontol A Biol Sci Med Sci; 2017 Jul; 72(suppl_1):S22-S25. PubMed ID: 28575258
[TBL] [Abstract][Full Text] [Related]
23. Impact of annual trend volume of low-dose computed tomography for lung cancer screening on overdiagnosis, overmanagement, and gender disparities.
Hsin-Hung C; En-Kuei T; Yun-Ju W; Fu-Zong W
Cancer Imaging; 2024 Jun; 24(1):73. PubMed ID: 38867342
[TBL] [Abstract][Full Text] [Related]
24. Performance of low-dose computed tomography on lung cancer screening in high-risk populations: The experience over five screening rounds in Sichuan, China.
Qiao L; Zhou P; Li B; Liu XX; Li LN; Chen YY; Ma J; Zhao YQ; Li TY; Li Q
Cancer Epidemiol; 2020 Dec; 69():101801. PubMed ID: 33017728
[TBL] [Abstract][Full Text] [Related]
25. Lung Cancer Screening: Use of Low-Dose Computed Tomography.
Martínez Pérez E; de Aguiar Quevedo K; Arrarás Martínez M; Cruz Mojarrieta J; Arana Fernández de Moya E; Barrios Benito M; Hinarejos Parga S; Cervera Deval J; Peñalver Cuesta JC
Arch Bronconeumol (Engl Ed); 2019 Oct; 55(10):526-531. PubMed ID: 31036378
[TBL] [Abstract][Full Text] [Related]
26. Lung cancer risk by years since quitting in 30+ pack year smokers.
Pinsky PF; Zhu CS; Kramer BS
J Med Screen; 2015 Sep; 22(3):151-7. PubMed ID: 25926339
[TBL] [Abstract][Full Text] [Related]
27. Impact of low-dose computed tomography screening on lung cancer mortality among asbestos-exposed workers.
Barbone F; Barbiero F; Belvedere O; Rosolen V; Giangreco M; Zanin T; Pisa FE; Meduri S; Follador A; Grossi F; Fasola G
Int J Epidemiol; 2018 Dec; 47(6):1981-1991. PubMed ID: 30325420
[TBL] [Abstract][Full Text] [Related]
28. Baseline computed tomography screening and blood microRNA predict lung cancer risk and define adequate intervals in the BioMILD trial.
Pastorino U; Boeri M; Sestini S; Sabia F; Milanese G; Silva M; Suatoni P; Verri C; Cantarutti A; Sverzellati N; Corrao G; Marchianò A; Sozzi G
Ann Oncol; 2022 Apr; 33(4):395-405. PubMed ID: 35091076
[TBL] [Abstract][Full Text] [Related]
29. Lung cancer screening with low dose CT: experience at Campus Bio-Medico of Rome on 1500 patients.
Crucitti P; Gallo IF; Santoro G; Mangiameli G
Minerva Chir; 2015 Dec; 70(6):393-9. PubMed ID: 25700151
[TBL] [Abstract][Full Text] [Related]
30. Individual and joint contributions of genetic and methylation risk scores for enhancing lung cancer risk stratification: data from a population-based cohort in Germany.
Yu H; Raut JR; Schöttker B; Holleczek B; Zhang Y; Brenner H
Clin Epigenetics; 2020 Jun; 12(1):89. PubMed ID: 32552915
[TBL] [Abstract][Full Text] [Related]
31. Exploring the Impact of Lung Cancer Screening on Lung Cancer Mortality of Smokers With Obstructive Lung Disease: Analysis of the NLST-ACRIN Cohort.
de-Torres JP; Wisnivesky JP; Bastarrika G; Wilson DO; Celli BR; Zulueta JJ
Arch Bronconeumol (Engl Ed); 2021 Jan; 57(1):36-41. PubMed ID: 32409195
[TBL] [Abstract][Full Text] [Related]
32. Low-dose chest computed tomography for lung cancer screening among Hodgkin lymphoma survivors: a cost-effectiveness analysis.
Wattson DA; Hunink MG; DiPiro PJ; Das P; Hodgson DC; Mauch PM; Ng AK
Int J Radiat Oncol Biol Phys; 2014 Oct; 90(2):344-53. PubMed ID: 25104066
[TBL] [Abstract][Full Text] [Related]
33. Lung Cancer Screening with Low-Dose CT in Female Never Smokers: Retrospective Cohort Study with Long-term National Data Follow-up.
Kim HY; Jung KW; Lim KY; Lee SH; Jun JK; Kim J; Hwangbo B; Lee JS
Cancer Res Treat; 2018 Jul; 50(3):748-756. PubMed ID: 28724283
[TBL] [Abstract][Full Text] [Related]
34. Cost-effectiveness of lung cancer screening with low-dose computed tomography in heavy smokers: a microsimulation modelling study.
Du Y; Sidorenkov G; Heuvelmans MA; Groen HJM; Vermeulen KM; Greuter MJW; de Bock GH
Eur J Cancer; 2020 Aug; 135():121-129. PubMed ID: 32563896
[TBL] [Abstract][Full Text] [Related]
35. Low-dose computed tomography (LDCT) versus other cancer screenings in early diagnosis of lung cancer: A meta-analysis.
Wang X; Liu H; Shen Y; Li W; Chen Y; Wang H
Medicine (Baltimore); 2018 Jul; 97(27):e11233. PubMed ID: 29979385
[TBL] [Abstract][Full Text] [Related]
36. Performance of the cancer risk management model lung cancer screening module.
Flanagan WM; Evans WK; Fitzgerald NR; Goffin JR; Miller AB; Wolfson MC
Health Rep; 2015 May; 26(5):11-8. PubMed ID: 25993046
[TBL] [Abstract][Full Text] [Related]
37. Lung cancer screening with low-dose computed tomography: National expenditures and cost-effectiveness.
Zeng X; Zhou Z; Luo X; Liu Q
Front Public Health; 2022; 10():977550. PubMed ID: 36249202
[TBL] [Abstract][Full Text] [Related]
38. [Risk factors for lung cancer based on low-dose computed tomography screening].
Jin YJ; Tang W; Huang Y; Wang JW; Hou DH; Qi LL; Zhao SJ; Wu N
Zhonghua Zhong Liu Za Zhi; 2020 Mar; 42(3):222-227. PubMed ID: 32252201
[No Abstract] [Full Text] [Related]
39. Smoking behaviors among patients receiving computed tomography for lung cancer screening. Systematic review in support of the U.S. preventive services task force.
Slatore CG; Baumann C; Pappas M; Humphrey LL
Ann Am Thorac Soc; 2014 May; 11(4):619-27. PubMed ID: 24701999
[TBL] [Abstract][Full Text] [Related]
40. Eligibility for low-dose computerized tomography screening among asbestos-exposed individuals.
Fitzgerald NR; Flanagan WM; Evans WK; Miller AB;
Scand J Work Environ Health; 2015 Jul; 41(4):407-12. PubMed ID: 25837734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
